Publications searcher

The science produced by our scientists is very important. In 2022, 1,629 papers were published in scientific journals with a global impact factor of over 15,000 points.

Pharmacokinetics of cefiderocol during extracorporeal membrane oxygenation: A case report.

PMID: 36853601
Journal: PERFUSION-UK
Year: 2023
Reference: Perfusion. 2023 May;38(1_suppl):40-43. doi: 10.1177/02676591231160462. Epub 2023 Feb 28.
Impact factor:
Publication type: Paper in international publication
Authors: Domenech, Josep; Domenech, Laura; Ferrer, Ricard; Gallart, Elisabet; Garcia, Sonia; Garcia, Sonia; Giron, Pilar; Lamora, Anna; Lamora, Anna; Nuvials, Xavier et al.
DOI: 10.1177/02676591231160462

Pharmacokinetics (PK) of Tiragolumab in First-in-Human Study in Patients With Mixed Solid Tumors (GO30103).

PMID: 38105505
Journal: JOURNAL OF CLINICAL PHARMACOLOGY
Year: 2023
Reference: J Clin Pharmacol. 2023 Dec 17. doi: 10.1002/jcph.2397.
Impact factor:
Publication type: Paper in international publication
Authors: Bedard, Philippe L; Calvo, Emiliano; Cervantes, Andres; Cho, Byoung Chul; Delord, Jean-Pierre; Ding, Hao; Garralda, Elena; Hendricks, Robert; Italiano, Antoine; Kim, Tae Won et al.
DOI: 10.1002/jcph.2397

Phase 1 first-in-human dose-escalation study of ANV419 in patients with relapsed/refractory advanced solid tumors.

PMID: 38243906
Journal: Journal for ImmunoTherapy of Cancer
Year: 2023
Reference: J Immunother Cancer. 2023 Nov 21;11(11):e007784. doi: 10.1136/jitc-2023-007784.
Impact factor:
Publication type: Paper in international publication
Authors: Alonso, Guzman; Alonso-Saladrigues, Anna; Bucher, Christoph; Caballero-Velazquez, Teresa; Calvo, Emiliano; Castillo-Robleda, Ana; Corral de la Fuente, Elena; Delgado-Serrano, Javier; Diaz-de-Heredia, Cristina; Faura, Anna et al.
DOI: 10.1136/jitc-2023-007784

Phase 1 study of JNJ-64619178, a protein arginine methyltransferase 5 inhibitor, in patients with lower-risk myelodysplastic syndromes.

PMID: 37776843
Journal: LEUKEMIA RESEARCH
Year: 2023
Reference: Leuk Res. 2023 Sep 20;134:107390. doi: 10.1016/j.leukres.2023.107390.
Impact factor:
Publication type: Paper in international publication
Authors: Alfonso-Pierola, Ana; Avivi, Irit; Brown, Regina J; Brunner, Andrew M; Cadenas, Felix Lopez; Chromik, Joerg; Falantes, Jose; Germing, Ulrich; Gu, Junchen; Haque, Tamanna et al.
DOI: 10.1016/j.leukres.2023.107390

Phase 2 trial of bintrafusp alfa as second-line therapy for patients with locally advanced/metastatic biliary tract cancers.

PMID: 36999533
Journal: HEPATOLOGY
Year: 2023
Reference: Hepatology. 2023 Sep 1;78(3):758-770. doi: 10.1097/HEP.0000000000000365. Epub 2023 Apr 1.
Impact factor:
Publication type: Paper in international publication
Authors: Azad, Nilofer; Bajars, Marcis; Borad, Mitesh J; Bridgewater, John; Cubillo, Antonio; de Braud, Filippo; Furuse, Junji; Hijioka, Susumu; Javle, Milind M; Kim, Jin Won et al.
DOI: 10.1097/HEP.0000000000000365

Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer.

PMID: 37870969
Journal: NEW ENGLAND JOURNAL OF MEDICINE
Year: 2023
Reference: N Engl J Med. 2023 Oct 21. doi: 10.1056/NEJMoa2309719.
Impact factor:
Publication type: Paper in international publication
Authors: Adam-Artigues, Anna; Arenas, Enrique J; Arribas, Joaquin; Bardet, Stephane; Brose, Marcia S; Capdevila, Jaume; Cejalvo, Juan Miguel; Elisei, Rossella; Fuhrer, Dagmar; Gao, Ming et al.
DOI: 10.1056/NEJMoa2309719

Phase Ia/b Study of Giredestrant +/-Palbociclib and +/-Luteinizing Hormone-releasing Hormone Agonists in Estrogen Receptor-positive, HER2-negative, Locally Advanced/Metastatic Breast Cancer.

PMID: 37921755
Journal: CLINICAL CANCER RESEARCH
Year: 2023
Reference: Clin Cancer Res. 2023 Nov 3. doi: 10.1158/1078-0432.CCR-23-1796.
Impact factor:
Publication type: Paper in international publication
Authors: Bardia, Aditya; Bellet-Ezquerra, Meritxell; Bond, John W; Boni, Valentina; Buti, Maria; Casado, Miguel Angel; Chang, Ching-Wei; Dominguez-Hernandez, Raquel; Eng-Wong, Jennifer; Esteban, Rafael et al.
DOI: 10.1158/1078-0432.CCR-23-1796

Phase II Study Investigating the Safety and Efficacy of Savolitinib and Durvalumab in Metastatic Papillary Renal Cancer (CALYPSO).

PMID: 36809050
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2023
Reference: J Clin Oncol. 2023 May 10;41(14):2493-2502. doi: 10.1200/JCO.22.01414. Epub 2023 Feb 21.
Impact factor:
Publication type: Paper in international publication
Authors: Glen, Hilary; Hartmaier, Ryan; Larkin, James M G; Markovets, Aleksandra; Mendez-Vidal, Maria Jose; Mousa, Kelly; Patel, Poulam; Powles, Thomas; Prendergast, Aaron; Ralph, Christy et al.
DOI: 10.1200/JCO.22.01414

Phase II trial of afatinib in patients with advanced urothelial carcinoma with genetic alterations in ERBB1-3 (LUX-Bladder 1).

PMID: 38102226
Journal: BRITISH JOURNAL OF CANCER
Year: 2023
Reference: Br J Cancer. 2023 Dec 15. doi: 10.1038/s41416-023-02513-6.
Impact factor:
Publication type: Paper in international publication
Authors: Aldecoa, Iban; Araujo, Silvia G; Buti, Maria; Castellano, Daniel; Climent, Miguel A; Fernandez, Emma; Fernandez, Pedro L; Font, Albert; Forns, Xavier; Gibson, Neil et al.
DOI: 10.1038/s41416-023-02513-6

Phase II Trial of Atezolizumab Combined With Carboplatin and Pemetrexed for Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer With Untreated Brain Metastases (Atezo-Brain, GECP17/05).

PMID: 37603816
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2023
Reference: J Clin Oncol. 2023 Aug 21:JCO2202561. doi: 10.1200/JCO.22.02561.
Impact factor:
Publication type: Paper in international publication
Authors: Blasco, Ana; Bruna, Jordi; De Castro, Javier; Estival, Anna; Felip, Enriqueta; Guirado, Maria; Huidobro, Gerardo; Juan, Oscar; Lopez, Rafael; Massuti, Bartomeu et al.
DOI: 10.1200/JCO.22.02561

Philadelphia-negative chronic myeloproliferative neoplasm follow-up: when the phone rings. Changes during the COVID-19 pandemic and patient satisfaction. Experience in 30 health centers in Spain.

PMID: 36422672
Journal: ANNALS OF HEMATOLOGY
Year: 2023
Reference: Ann Hematol. 2023 Feb;102(2):447-456. doi: 10.1007/s00277-022-05044-x. Epub 2022 Nov 23.
Impact factor:
Publication type: Paper in international publication
Authors: Alvarez-Larran, Alberto; Blum Dominguez, Alejandra; Caballero Navarro, Gonzalo; Caceres Sansaloni, Amparo; Carbonell, Sara; Cobo Rodriguez, Maria Teresa; Diaz, Alvaro; Duran, M Antonia; Fernandez Rodriguez, Angeles; Fox, Maria Laura et al.
DOI: 10.1007/s00277-022-05044-x

PHYOX2: A Pivotal Randomized Study of Nedosiran in Primary Hyperoxaluria Type 1 or 2.

PMID: 36007597
Journal: KIDNEY INTERNATIONAL
Year: 2023
Reference: Kidney Int. 2023 Jan;103(1):207-217. doi: 10.1016/j.kint.2022.07.025. Epub 2022 Aug 22.
Impact factor:
Publication type: Paper in international publication
Authors: Amrite, Aniruddha; Ariceta, Gema; Baum, Michelle A; Belostotsky, Vladimir; Cochat, Pierre; Forbes, Thomas A; Groothoff, Jaap; Hamamoto, Shuzo; Hayes, Wesley; Hoppe, Bernd et al.
DOI: 10.1016/j.kint.2022.07.025

Physical activity and exercise for the prevention and management of mild cognitive impairment and dementia: a collaborative international guideline.

PMID: 37768499
Journal: European Geriatric Medicine
Year: 2023
Reference: Eur Geriatr Med. 2023 Sep 28. doi: 10.1007/s41999-023-00858-y.
Impact factor:
Publication type: Paper in international publication
Authors: Alves, Mariana; Ars, Joan; Ars, Joan; Bahat, Gulistan; Barbagallo, Mario; Barbagallo, Mario; Bauer, Jurgen; Bautman, Ivan; Bazan, Laura Monica Perez; Brugiavini, Agar et al.
DOI: 10.1007/s41999-023-00858-y

Physical Activity in Multiple Sclerosis: Meeting the Guidelines at the Time of the COVID-19 Pandemic.

PMID: 36753458
Journal: Journal of Neurologic Physical Therapy
Year: 2023
Reference: J Neurol Phys Ther. 2023 Apr 1;47(2):112-121. doi: 10.1097/NPT.0000000000000430. Epub 2023 Jan 31.
Impact factor:
Publication type: Paper in international publication
Authors: Arntzen, Ellen Christin; Coote, Susan; Gungor, Feray; Jonsdottir, Johanna; Kalron, Alon; Kos, Daphne; Learmonth, Yvonne; Moumdjian, Lousin; Nedeljkovic, Una; Novotna, Klara et al.
DOI: 10.1097/NPT.0000000000000430

Pituitary macroadenomas in childhood and adolescence: a clinical analysis of 7 patients.

PMID: 37908013
Journal:
Year: 2023
Reference: Clin Diabetes Endocrinol. 2023 Oct 31;9(1):5. doi: 10.1186/s40842-023-00153-6.
Impact factor:
Publication type: Paper in international publication
Authors: Abbas, Amr E; Aguilar-Riera, Cristina; Al-Azizi, Karim M; Biagetti, Betina; Calabuig, Alvaro; Campos-Martorell, Ariadna; Clemente, Maria; Conradi, Lenard; Fabregas, Anna; Fernandez-Nofrerias, Eduard et al.
DOI: 10.1186/s40842-023-00153-6

Plain language summary of the CheckMate 816 study results: nivolumab plus chemotherapy given before surgery for non-small-cell lung cancer.

PMID: 36815433
Journal: Future Oncology
Year: 2023
Reference: Future Oncol. 2023 Feb 23. doi: 10.2217/fon-2023-0007.
Impact factor:
Publication type: Letter or abstract
Authors: Awad, Mark M; Balli, David; Brahmer, Julie R; Broderick, Stephen R; Cai, Junliang; Calvet, Christophe Y; Chen, Ke Neng; Ciuleanu, Tudor-Eliade; Dorange, Cecile; Felip, Enriqueta et al.
DOI: 10.2217/fon-2023-0007

Plasmatic BRAF-V600E allele fraction as a prognostic factor in metastatic colorectal cancer treated with BRAF combinatorial treatments.

PMID: 36921693
Journal: ANNALS OF ONCOLOGY
Year: 2023
Reference: Ann Oncol. 2023 Jun;34(6):543-552. doi: 10.1016/j.annonc.2023.02.016. Epub 2023 Mar 14.
Impact factor:
Publication type: Paper in international publication
Authors: Antista, M; Baraibar, I; Boccaccino, A; Comas, R; Cremolini, C; Dientsmann, R; Elez, E; Garcia, A; Martin, A; Martinelli, E et al.
DOI: 10.1016/j.annonc.2023.02.016

Platelet Analysis in the Thrombus Plus Serum BNP for Detecting Clot-Related Atrial Fibrillation. Results From the ITACAT Multicentric Registry.

PMID: 38091189
Journal: Translational Stroke Research
Year: 2023
Reference: Transl Stroke Res. 2023 Dec 13. doi: 10.1007/s12975-023-01220-x.
Impact factor:
Publication type: Paper in international publication
Authors: Camacho, Jessica; de-la-Torre, Carolina; Dorado, Laura; Garcia-Tornel, Alvaro; Hernandez, David; Hernandez-Perez, Maria; Juega, Jesus; Lazaro, Carlos; Molina, Carlos; Muchada, Marian et al.
DOI: 10.1007/s12975-023-01220-x

Platform trials as the way forward in infectious disease' clinical research: the case of COVID-19.

PMID: 36462745
Journal: CLINICAL MICROBIOLOGY AND INFECTION
Year: 2023
Reference: Clin Microbiol Infect. 2023 Mar;29(3):277-280. doi: 10.1016/j.cmi.2022.11.022. Epub 2022 Dec 1.
Impact factor:
Publication type: Letter or abstract
Authors: Berry, Scott M; Derde, Lennie Pg; Pericas, Juan M et al.
DOI: 10.1016/j.cmi.2022.11.022

Platform trials to overcome major shortcomings of traditional clinical trials in non-alcoholic steatohepatitis? Pros and Cons.

PMID: 36216134
Journal: JOURNAL OF HEPATOLOGY
Year: 2023
Reference: J Hepatol. 2023 Feb;78(2):442-447. doi: 10.1016/j.jhep.2022.09.021. Epub 2022 Oct 8.
Impact factor:
Publication type: Review in international publication
Authors: Aaes-Jorgensen, Anders; Anstee, Quentin M; Anstee, Quentin M; Balthaus, Tania; Capuano, George; de Preville, Natalie; Di Prospero, Nicholas A; Di Prospero, Nicholas A; Duca, Anna; Genesca, Joan et al.
DOI: 10.1016/j.jhep.2022.09.021

Point-of-care ultrasound for tuberculosis diagnosis in children: a Medecins Sans Frontieres cross-sectional study in Guinea-Bissau.

PMID: 37208138
Journal: BMJ Open
Year: 2023
Reference: BMJ Open. 2023 May 19;13(5):e066937. doi: 10.1136/bmjopen-2022-066937.
Impact factor:
Publication type: Paper in international publication
Authors: Alonso, Beatriz; Belard, Sabine; Biague, Evelize; Burza, Sakib; Camara, Miguel; Fonseca, Jamila Vieira; Gallo, Jonathan; Goncalves, Ramiro; Heuvelings, Lotje; Llosa, Augusto E et al.
DOI: 10.1136/bmjopen-2022-066937

Polyoxazoline-Based Nanovaccine Synergizes with Tumor-Associated Macrophage Targeting and Anti-PD-1 Immunotherapy against Solid Tumors.

PMID: 37434063
Journal: Advanced Science
Year: 2023
Reference: Adv Sci (Weinh). 2023 Jul 11:e2300299. doi: 10.1002/advs.202300299.
Impact factor:
Publication type: Paper in international publication
Authors: Acurcio, Rita C; Afonso, Marta B; Arango, Diego; Carreira, Barbara; Florindo, Helena F; Gois, Pedro M P; Graca, Luis; Jordan, Rainer; Martinez-Barriocanal, Agueda; Matos, Ana I et al.
DOI: 10.1002/advs.202300299

Pooled Safety Analysis of Single-Agent Lurbinectedin in Patients With Advanced Solid Tumours.

PMID: 37634282
Journal: EUROPEAN JOURNAL OF CANCER
Year: 2023
Reference: Eur J Cancer. 2023 Jul 28;192:113259. doi: 10.1016/j.ejca.2023.113259.
Impact factor:
Publication type: Paper in international publication
Authors: Boni, Valentina; Brana, Irene; Cullell-Young, Martin; Delord, Jean-Pierre; Fernandez, Cristian; Kahatt, Carmen; Leary, Alexandra; Moreno, Victor; Nieto, Antonio; Oaknin, Ana et al.
DOI: 10.1016/j.ejca.2023.113259

Poor sleep is associated with deficits of attention in COPD patients.

PMID: 37866212
Journal: SLEEP MEDICINE
Year: 2023
Reference: Sleep Med. 2023 Oct 15;112:165-172. doi: 10.1016/j.sleep.2023.10.008.
Impact factor:
Publication type: Paper in international publication
Authors: Ferrer, Jaume; Ferrer, Jaume; Miravitlles, Marc; Miravitlles, Marc; Romero, Odile; Romero, Odile; Saez, Maria; Saez, Maria; Sampol, Gabriel; Sampol, Gabriel et al.
DOI: 10.1016/j.sleep.2023.10.008

Publications